By transplanting ABCG2-proficient Brca1−/−;p53−/− mammary tumors derived from FVB/N mice into ABCG2-deficient hosts of the same strain, we show here that Ko143 is indeed useful for reversing ABCG2-mediated topotecan resistance in vivo. Here, TP53 is linked to breast cancer.